Debra Cafaro - Ventas Chairman of the Board, Chief Executive Officer
| VTR Stock | USD 68.28 0.13 0.19% |
Chairman
Ms. Debra A. Cafaro is Chairman of the Board, Chief Executive Officer of Ventas, Inc. She was our Chief Executive Officer and a director since 1999 and Chairman of the Board since 2003. She also served as our President from 1999 to November 2010. She is the Chair Elect of the Real Estate Roundtable and serves on the Executive Committee of the Boards of the Real Estate Roundtable and the Economic Club of Chicago. She is an owner and member of the Management Committee of the Pittsburgh Penguins, a National Hockey League team since 2010.
| Age | 67 |
| Tenure | 15 years |
| Address | 353 North Clark Street, Chicago, IL, United States, 60654-4708 |
| Phone | 877 483 6827 |
| Web | https://www.ventasreit.com |
Debra Cafaro Latest Insider Activity
Tracking and analyzing the buying and selling activities of Debra Cafaro against Ventas stock is an integral part of due diligence when investing in Ventas. Debra Cafaro insider activity provides valuable insight into whether Ventas is net buyers or sellers over its current business cycle. Note, Ventas insiders must abide by specific rules, including filing SEC forms every time they buy or sell Ventas'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Debra Cafaro over a month ago Acquisition by Debra Cafaro of 34085 shares of Ventas at 65.94 subject to Rule 16b-3 | ||
Debra Cafaro over three months ago Disposition of 6827 shares by Debra Cafaro of Ventas at 63.196 subject to Rule 16b-3 | ||
Debra Cafaro over three months ago Disposition of 8154 shares by Debra Cafaro of Ventas at 63.0391 subject to Rule 16b-3 | ||
Debra Cafaro over six months ago Disposition of 38434 shares by Debra Cafaro of Ventas at 60.1364 subject to Rule 16b-3 |
Ventas Management Efficiency
The company has Return on Asset of 0.018 % which means that on every $100 spent on assets, it made $0.018 of profit. This is way below average. Ventas' management efficiency ratios could be used to measure how well Ventas manages its routine affairs as well as how well it operates its assets and liabilities. As of 02/27/2025, Return On Tangible Assets is likely to drop to 0. In addition to that, Return On Capital Employed is likely to drop to 0.03. At this time, Ventas' Asset Turnover is relatively stable compared to the past year.Similar Executives
| Found 8 records | CHAIRMAN Age | ||
| Jeffrey JD | Global Medical REIT | 65 | |
| Jeffrey Busch | Global Medical REIT | 64 | |
| Tommy Thompson | Healthpeak Properties | 78 | |
| Jeffery Busch | Global Medical REIT | 64 | |
| Alan Miller | Universal Health Realty | 87 | |
| Craig Callen | Omega Healthcare Investors | 64 | |
| Richard Matros | Sabra Healthcare REIT | 71 | |
| John Singleton | Healthcare Realty Trust | 72 | |
Management Performance
| Return On Equity | 0.0084 | ||||
| Return On Asset | 0.018 |
Ventas Inc Leadership Team
Elected by the shareholders, the Ventas' board of directors comprises two types of representatives: Ventas inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ventas. The board's role is to monitor Ventas' management team and ensure that shareholders' interests are well served. Ventas' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ventas' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Edmund III, Chief VP | ||
| Carey JD, General VP | ||
| Jay Gellert, Independent Director | ||
| Richard JD, Senior Advisor | ||
| Maurice Smith, Independent Director | ||
| Richard Gilchrist, Independent Director | ||
| Louise Adhikari, VP Communications | ||
| Robert Probst, Chief Financial Officer, Executive Vice President | ||
| J Hutchens, Executive Vice President - Senior Housing | ||
| Roxanne Martino, Independent Director | ||
| Justin Hutchens, Executive Officer | ||
| Randy Sohanaki, Vice President - IT Applications | ||
| Julie Robinson, Senior Investments | ||
| Brian Wood, Chief VP | ||
| John Cobb, Executive Vice President, Chief Investment Officer | ||
| Peter Bulgarelli, Executive Vice President and President and Chief Executive Officer, Lillibridge Healthcare Services, Inc. | ||
| Bhavana Devulapally, Senior Vice President, Chief Information Officer | ||
| Michael Embler, Independent Director | ||
| Walter Rakowich, Independent Director | ||
| Debra Cafaro, Chairman of the Board, Chief Executive Officer | ||
| Gregory Liebbe, Senior Vice President Chief Accounting Officer, Controller | ||
| Robert Reed, Independent Director | ||
| Timothy Sanders, Senior Investment Officer | ||
| Christian Cummings, Senior Housing | ||
| Melody Barnes, Independent Director | ||
| James Shelton, Presiding Independent Director | ||
| Matthew Lustig, Independent Director | ||
| Sean Nolan, Independent Director | ||
| Carey Roberts, Executive Vice President General Counsel and Ethics & Compliance Officer | ||
| Marguerite Nader, Independent Director |
Ventas Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ventas a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0084 | ||||
| Return On Asset | 0.018 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 42.63 B | ||||
| Shares Outstanding | 437.14 M | ||||
| Shares Owned By Insiders | 0.60 % | ||||
| Shares Owned By Institutions | 99.67 % | ||||
| Number Of Shares Shorted | 12.13 M | ||||
| Price To Earning | 909.80 X |
Additional Tools for Ventas Stock Analysis
When running Ventas' price analysis, check to measure Ventas' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ventas is operating at the current time. Most of Ventas' value examination focuses on studying past and present price action to predict the probability of Ventas' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ventas' price. Additionally, you may evaluate how the addition of Ventas to your portfolios can decrease your overall portfolio volatility.